Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase 3 2Phase 1/2 1

Status

Completed 4Terminated 2

Sponsor Class

NETWORK 3INDUSTRY 3

Study Type

Interventional 6

Sponsor

Cancer Type

Thoracic 2Sarcoma 2Gynecologic 1Gastrointestinal 1CNS 1

Conditions

Small Cell Lung Carcinoma 1Sarcoma 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Neoplasms 1Lung Neoplasms 1Gliosarcoma 1Glioblastoma 1Central Nervous System Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Brain Neoplasms 1

Interventions

Cisplatin 1519Carboplatin 1420Cyclophosphamide 1360Gemcitabine 1235Bevacizumab 1226Paclitaxel 1211Radiotherapy 1176Docetaxel 1080pembrolizumab 1028Oxaliplatin 936Capecitabine 901Fluorouracil 833Rituximab 729Doxorubicin 683Nivolumab 679Dexamethasone 666Etoposide 660Irinotecan 622Leucovorin 575Pemetrexed 510Drug Therapy 493Cetuximab 483Trastuzumab 469Cytarabine 466Magnetic Resonance Spectroscopy 458Filgrastim 446Prednisone 433Lenalidomide 409Specimen Handling 408Temozolomide 400

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 2 × beta-D-glucosylisophosphoramide mustard × Clear all
NCT00441467 2015-03-25

Safety and Efficacy Study of Glufosfamide in Previously Treated Advanced Soft Tissue Sarcoma

Eleison Pharmaceuticals LLC.

Phase 2 Completed
22 enrolled 9 charts
Sarcoma

Sarcoma

NCT00442598 2015-03-10

Safety and Efficacy Study of Glufosfamide in Ovarian Cancer

Eleison Pharmaceuticals LLC.

Phase 2 Terminated
17 enrolled 9 charts
Gynecologic

Neoplasms, Ovarian Neoplasms

NCT00005053 2012-09-24

Glufosfamide With or Without Hydration in Treating Patients With Advanced Pancreatic Cancer

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Completed
35 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT00005055 2012-09-24

Glufosfamide With of Without Hydration in Treating Patients With Advanced Non-small Cell Lung Cancer

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Completed
39 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00014300 2012-09-24

Glufosfamide in Treating Patients With Recurrent Glioblastoma Multiforme

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Completed
32 enrolled
CNSSarcoma

Brain Neoplasms, Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

NCT00435578 2009-04-30

Safety and Efficacy Study of Glufosfamide in Patients With Recurrent Sensitive Small Cell Lung Carcinoma

Threshold Pharmaceuticals

Phase 2 Terminated
50 enrolled
Thoracic

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡